Index RUT
P/E -
EPS (ttm) -1.28
Insider Own 5.09%
Shs Outstand 113.89M
Perf Week 0.58%
Market Cap 3.78B
Forward P/E 21.05
EPS next Y 1.56
Insider Trans -2.52%
Shs Float 109.55M
Perf Month -2.99%
Income -142.26M
PEG -
EPS next Q 0.23
Inst Own 110.35%
Short Float 9.87%
Perf Quarter -1.18%
Sales 1.96B
P/S 1.93
EPS this Y 23.81%
Inst Trans 5.23%
Short Ratio 10.89
Perf Half Y 22.35%
Book/sh 9.38
P/B 3.50
EPS next Y 44.63%
ROA -5.03%
Short Interest 10.81M
Perf Year 7.51%
Cash/sh 1.79
P/C 18.32
EPS next 5Y 30.00%
ROE -11.73%
52W Range 23.33 - 36.70
Perf YTD -0.73%
Dividend Est. 0.27 (0.82%)
P/FCF 33.25
EPS past 5Y -13.43%
ROI -7.56%
52W High -10.65%
Beta 1.54
Dividend TTM -
Quick Ratio 1.01
Sales past 5Y 27.32%
Gross Margin 17.11%
52W Low 40.55%
ATR (14) 0.84
Dividend Ex-Date -
Current Ratio 1.01
EPS Y/Y TTM -548.93%
Oper. Margin 1.57%
RSI (14) 51.28
Volatility 2.06% 2.24%
Employees 4700
Debt/Eq 0.77
Sales Y/Y TTM 45.26%
Profit Margin -7.24%
Recom 1.21
Target Price 45.23
Option/Short Yes / Yes
LT Debt/Eq 0.76
EPS Q/Q -220.49%
Payout -
Rel Volume 0.84
Prev Close 32.73
Sales Surprise 2.51%
EPS Surprise 38.14%
Sales Q/Q 45.40%
Earnings Feb 22 AMC
Avg Volume 992.45K
Price 32.79
SMA20 -1.55%
SMA50 3.07%
SMA200 11.88%
Trades
Volume 830,005
Change 0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Initiated
Oppenheimer
Outperform
$45
Jan-03-24 Initiated
Barclays
Overweight
$39
Dec-06-23 Initiated
JMP Securities
Mkt Outperform
$37
Oct-16-23 Initiated
UBS
Buy
$46
Apr-12-23 Initiated
Stephens
Overweight
$40
Nov-01-22 Initiated
Truist
Hold
$33
Jul-29-22 Initiated
RBC Capital Mkts
Outperform
$40
Mar-30-22 Initiated
Guggenheim
Buy
$43
Nov-18-21 Upgrade
JP Morgan
Neutral → Overweight
$26 → $37
Apr-29-21 Resumed
JP Morgan
Neutral
$23
Jan-07-21 Initiated
BTIG Research
Buy
$20
Jul-06-20 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jun-05-20 Downgrade
Goldman
Buy → Neutral
$13 → $8
Jun-02-20 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$9 → $8
Oct-05-18 Resumed
Leerink Partners
Outperform
$35
Jun-04-18 Initiated
Piper Jaffray
Overweight
$30
Apr-24-18 Resumed
JP Morgan
Neutral
$17
Sep-20-17 Initiated
KeyBanc Capital Mkts
Overweight
$23
Jun-02-17 Initiated
Robert W. Baird
Outperform
$30
Mar-14-17 Initiated
Oppenheimer
Outperform
Show Previous Ratings
Mar-14-24 09:55AM
Feb-27-24 09:55AM
Feb-23-24 11:39AM
07:54AM
(Thomson Reuters StreetEvents)
01:15AM
05:06PM
Loading…
Feb-22-24 05:06PM
(Associated Press Finance)
04:37PM
04:10PM
Feb-14-24 04:10PM
Jan-25-24 07:00AM
Dec-07-23 09:55AM
01:05AM
Dec-06-23 08:10AM
Dec-05-23 10:59PM
07:00AM
09:55AM
Loading…
Nov-20-23 09:55AM
Nov-05-23 05:18PM
Nov-03-23 05:30AM
Nov-02-23 07:09PM
06:50PM
05:49PM
(Associated Press Finance)
04:10PM
Oct-26-23 07:52AM
Oct-25-23 07:30PM
Oct-23-23 09:55AM
Oct-10-23 05:30PM
09:15AM
Oct-06-23 09:55AM
Oct-05-23 12:00PM
Aug-24-23 05:20PM
05:00PM
Loading…
Aug-08-23 05:00PM
Aug-04-23 09:51AM
Aug-02-23 10:30PM
07:35PM
06:32PM
04:10PM
Jul-26-23 04:42PM
Jul-13-23 04:15PM
Jul-11-23 09:00AM
Jul-03-23 09:51AM
May-22-23 07:50AM
May-09-23 07:30AM
May-05-23 12:40PM
May-04-23 11:47AM
(Thomson Reuters StreetEvents)
02:00AM
May-03-23 06:45PM
05:34PM
04:10PM
Apr-19-23 04:10PM
Apr-18-23 01:10PM
Apr-17-23 04:45PM
Mar-30-23 11:10AM
Mar-29-23 04:10PM
Mar-27-23 07:29AM
Mar-08-23 06:30AM
Mar-03-23 08:00AM
Feb-24-23 05:44AM
Feb-23-23 01:10PM
Feb-22-23 10:00PM
06:55PM
04:10PM
Feb-09-23 08:15AM
Feb-02-23 05:18AM
Jan-31-23 05:00PM
Jan-23-23 12:20PM
(American City Business Journals)
11:58AM
Jan-03-23 05:37AM
Dec-13-22 05:36AM
Nov-29-22 04:15PM
Nov-18-22 03:01PM
11:21AM
06:50AM
Nov-17-22 06:37PM
(American City Business Journals)
04:45PM
04:01PM
Nov-16-22 06:42PM
Nov-15-22 09:49AM
Nov-04-22 09:35AM
Nov-02-22 10:30PM
07:05PM
04:10PM
Oct-20-22 09:40AM
Oct-17-22 12:11PM
Oct-14-22 09:18AM
Oct-04-22 09:40AM
Sep-30-22 07:30AM
Sep-22-22 09:25AM
Sep-09-22 05:00AM
Sep-06-22 05:22PM
(American City Business Journals)
04:15PM
Aug-10-22 12:00PM
11:55AM
Aug-08-22 09:55AM
Aug-05-22 07:42AM
Aug-03-22 02:48PM
08:10AM
(Investor's Business Daily)
Aug-02-22 11:30PM
06:45PM
04:55PM
(Investor's Business Daily)
04:10PM
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Blackley Seth Chief Executive Officer Dec 05 '23 Sale 26.54 141,000 3,741,475 637,645 Dec 06 04:49 PM Blackley Seth Chief Executive Officer Dec 04 '23 Option Exercise 0.00 280,000 0 778,645 Dec 06 04:49 PM McCarthy Daniel Joseph PRESIDENT Nov 15 '23 Option Exercise 10.65 3,000 31,950 201,333 Nov 20 08:01 AM McCarthy Daniel Joseph PRESIDENT Nov 15 '23 Sale 30.00 11,000 330,000 198,333 Nov 20 08:01 AM Rafferty Emily Ann Chief Operating Officer Aug 15 '23 Sale 28.05 7,900 221,595 70,897 Aug 17 04:35 PM Blackley Seth Chief Executive Officer Jun 28 '23 Option Exercise 3.84 33,011 126,762 816,022 Jun 30 04:27 PM Blackley Seth Chief Executive Officer Jun 28 '23 Sale 30.78 33,011 1,016,022 783,011 Jun 30 04:27 PM Blackley Seth Chief Executive Officer Jun 16 '23 Option Exercise 3.84 2,098 8,056 785,109 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 16 '23 Sale 30.16 2,098 63,276 783,011 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 15 '23 Option Exercise 3.84 75,931 291,575 858,942 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 15 '23 Sale 30.20 75,931 2,293,116 783,011 Jun 20 04:36 PM Scott Cheryl Director Jun 14 '23 Sale 30.01 2,365 70,974 53,788 Jun 16 04:38 PM DUFFY MARY BRIDGET Director Jun 13 '23 Sale 30.97 5,564 172,317 49,935 Jun 15 04:24 PM Holder Diane Director Jun 12 '23 Sale 31.26 12,000 375,120 60,140 Jun 14 05:04 PM McCarthy Daniel Joseph PRESIDENT Jun 12 '23 Sale 31.44 1,000 31,440 206,333 Jun 14 05:01 PM WILLIAMS FRANK J Director Jun 01 '23 Option Exercise 9.68 110,000 1,064,896 929,812 Jun 05 04:23 PM WILLIAMS FRANK J Director Jun 01 '23 Sale 29.52 110,000 3,247,108 819,812 Jun 05 04:23 PM WILLIAMS FRANK J Director May 01 '23 Option Exercise 6.87 110,000 755,700 929,812 May 03 04:24 PM WILLIAMS FRANK J Director May 01 '23 Sale 36.29 110,000 3,991,900 819,812 May 03 04:24 PM WILLIAMS FRANK J Director Apr 03 '23 Option Exercise 6.87 110,000 755,700 929,812 Apr 05 04:43 PM WILLIAMS FRANK J Director Apr 03 '23 Sale 31.83 110,000 3,501,348 819,812 Apr 05 04:43 PM
Index S&P 500
P/E 23.97
EPS (ttm) 3.15
Insider Own 1.43%
Shs Outstand 129.25M
Perf Week 1.94%
Market Cap 9.71B
Forward P/E 13.33
EPS next Y 5.66
Insider Trans -4.48%
Shs Float 126.67M
Perf Month -1.27%
Income 416.00M
PEG 3.31
EPS next Q 1.02
Inst Own 99.29%
Short Float 4.66%
Perf Quarter -0.42%
Sales 12.34B
P/S 0.79
EPS this Y 12.80%
Inst Trans 0.51%
Short Ratio 5.14
Perf Half Y 3.08%
Book/sh 28.28
P/B 2.67
EPS next Y 11.60%
ROA 4.34%
Short Interest 5.90M
Perf Year -5.19%
Cash/sh 1.33
P/C 56.75
EPS next 5Y 7.25%
ROE 11.72%
52W Range 60.01 - 85.75
Perf YTD -0.25%
Dividend Est. -
P/FCF 31.01
EPS past 5Y -1.96%
ROI 7.05%
52W High -11.93%
Beta 0.87
Dividend TTM -
Quick Ratio 1.00
Sales past 5Y 5.89%
Gross Margin 29.59%
52W Low 25.85%
ATR (14) 1.53
Dividend Ex-Date -
Current Ratio 1.67
EPS Y/Y TTM -19.28%
Oper. Margin 5.63%
RSI (14) 53.85
Volatility 1.92% 1.72%
Employees 25000
Debt/Eq 0.75
Sales Y/Y TTM -2.44%
Profit Margin 3.37%
Recom 2.67
Target Price 81.32
Option/Short Yes / Yes
LT Debt/Eq 0.61
EPS Q/Q -60.20%
Payout 0.00%
Rel Volume 0.88
Prev Close 75.15
Sales Surprise -0.64%
EPS Surprise -5.20%
Sales Q/Q -10.50%
Earnings Feb 27 BMO
Avg Volume 1.15M
Price 75.52
SMA20 0.96%
SMA50 0.55%
SMA200 1.64%
Trades
Volume 1,014,929
Change 0.49%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade
JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade
Stifel
Hold → Buy
$70
Aug-08-22 Upgrade
UBS
Sell → Neutral
$80
Jul-21-22 Downgrade
Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade
Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed
Credit Suisse
Outperform
$100
Jan-31-22 Initiated
Morgan Stanley
Underweight
$67
Jan-07-22 Upgrade
Credit Suisse
Neutral → Outperform
$78 → $90
Oct-01-21 Resumed
Credit Suisse
Neutral
$78
Feb-08-21 Resumed
Piper Sandler
Overweight
$83
Jan-04-21 Upgrade
Robert W. Baird
Neutral → Outperform
$70 → $79
Nov-03-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$72
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Apr-07-20 Upgrade
Goldman
Neutral → Buy
$64 → $59
Apr-02-20 Upgrade
Wolfe Research
Peer Perform → Outperform
$68
Jan-09-20 Downgrade
BofA/Merrill
Neutral → Underperform
Jan-02-20 Upgrade
Evercore ISI
Underperform → In-line
$61 → $70
Aug-07-19 Downgrade
William Blair
Outperform → Mkt Perform
May-30-19 Initiated
Wolfe Research
Underperform
Show Previous Ratings
Today 11:30AM
Mar-21-24 07:00PM
Mar-19-24 07:00PM
Mar-10-24 10:08AM
Mar-06-24 11:55PM
06:30AM
Loading…
Mar-04-24 06:30AM
Feb-28-24 09:09AM
02:21AM
(Thomson Reuters StreetEvents)
Feb-27-24 09:30AM
08:44AM
07:32AM
07:10AM
06:32AM
06:18AM
(Associated Press Finance)
06:00AM
05:30AM
Loading…
05:30AM
Feb-22-24 09:15AM
06:30AM
Feb-21-24 06:30AM
Feb-19-24 08:00AM
Feb-16-24 08:38AM
Feb-14-24 06:30AM
Feb-07-24 09:00AM
Feb-01-24 09:32AM
Jan-25-24 07:00AM
Jan-23-24 08:57AM
06:30AM
Jan-03-24 06:30AM
Dec-27-23 10:09AM
Dec-23-23 07:01PM
11:39AM
Loading…
Dec-21-23 11:39AM
Dec-20-23 07:00AM
Dec-18-23 04:12PM
Dec-15-23 06:30AM
Dec-13-23 11:30AM
Dec-08-23 07:25AM
Dec-05-23 07:37AM
Dec-04-23 02:00AM
Dec-03-23 04:00PM
Nov-30-23 06:29AM
Nov-28-23 06:30AM
Nov-16-23 05:10PM
Nov-14-23 01:19PM
07:20AM
05:50AM
(Thomson Reuters StreetEvents)
Nov-13-23 05:25PM
04:50PM
03:56PM
12:37PM
10:59AM
09:30AM
07:15AM
07:00AM
06:58AM
06:07AM
(Associated Press Finance)
06:00AM
06:00AM
Nov-10-23 11:50AM
Nov-08-23 04:00PM
07:00AM
Nov-07-23 07:00AM
Nov-02-23 04:10PM
10:00AM
Oct-31-23 10:01AM
Oct-30-23 08:41AM
Oct-25-23 05:20AM
Oct-24-23 09:05AM
Oct-18-23 09:40AM
12:30AM
Oct-17-23 04:15PM
09:40AM
Oct-16-23 04:59PM
12:13PM
(Associated Press Finance)
12:11PM
11:36AM
09:45AM
Oct-15-23 11:30PM
Oct-10-23 11:40AM
09:50AM
Oct-05-23 08:30AM
Oct-04-23 08:41AM
06:31AM
Sep-27-23 12:34PM
09:45AM
Sep-26-23 11:10AM
Sep-20-23 09:40AM
Sep-14-23 06:30AM
Sep-08-23 09:45AM
Sep-06-23 11:30AM
06:30AM
Sep-05-23 06:30AM
Aug-29-23 06:50PM
11:02AM
09:40AM
Aug-17-23 06:31AM
Aug-10-23 02:00PM
09:06AM
Aug-09-23 06:31AM
Aug-08-23 01:46AM
(Thomson Reuters StreetEvents)
Aug-07-23 12:36PM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Connett Bradford C CEO, NA Distribution Group Mar 20 '24 Sale 74.28 6,430 477,620 73,108 Mar 21 04:18 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 18 '24 Sale 74.37 2,907 216,194 209,562 Mar 19 04:11 PM LASKAWY PHILIP A Director Mar 05 '24 Sale 76.29 4,278 326,369 24,565 Mar 06 04:54 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 04 '24 Sale 76.50 2,907 222,386 212,469 Mar 05 04:27 PM KUEHN KURT P Director Mar 01 '24 Sale 77.07 1,582 121,925 13,598 Mar 05 04:52 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 13,962 1,049,105 168,633 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 5,820 437,315 481,450 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 26,190 1,965,036 182,595 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 10,914 818,877 487,270 Dec 27 04:10 PM Connett Bradford C CEO, NA Distribution Group Dec 21 '23 Sale 74.02 11,238 831,837 57,831 Dec 22 04:02 PM Brous David B Jr CEO, Strategic Business Group Jun 12 '23 Sale 74.86 11,157 835,191 68,690 Jun 13 04:35 PM Siegel Walter Sr. VP & Chief Legal Officer Jun 05 '23 Sale 74.07 5,497 407,163 35,737 Jun 07 04:07 PM BRESLAWSKI JAMES P Vice Chairman, President Jun 02 '23 Sale 74.29 24,234 1,800,453 201,555 Jun 06 04:04 PM Ettinger Michael S EVP & Chief Operating Officer May 24 '23 Sale 75.12 14,881 1,117,861 75,710 May 25 04:48 PM MLOTEK MARK E EVP, Chief Strategic Officer May 19 '23 Sale 76.68 24,747 1,897,600 69,138 May 23 04:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite